EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Design, Synthesis and Biophysical Characterisation of CPP‐PNA Conjugates for Targeting Oncogenic microRNA‐221

Martina Rotondo, Françoise Illien iD, Fabienne Burlina iD, Barbara Biondi iD

Journal of Peptide Science · 2026

DOI: 10.1002/psc.70129 ↗

At a glance

Journal article in Journal of Peptide Science, 2026. Written by Martina Rotondo and 3 co-authors. Institution: University of Naples Federico II, Naples, Italy. Major MEDLINE topics: Peptide Nucleic Acids, MicroRNAs, Cell-Penetrating Peptides, Drug Design. 59 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Peptide nucleic acids (PNAs) are a promising platform targeting disease‐associated microRNAs due to their high binding affinity, excellent sequence specificity and resistance to enzymatic degradation. However, their therapeutic application is often limited by inefficient cellular uptake. In this study, we present the design, synthesis and physicochemical characterisation of cell‐penetrating peptide (CPP)‐PNA conjugates that target the oncogenic microRNA miRNA‐221‐5p, as well as their preliminary biological evaluation. Anti‐miRNA‐221‐5p PNAs functionalised for conjugation with CPPs via Cu(I)‐catalysed azide‐alkyne cycloaddition (CuAAC) or disulfide‐mediated coupling were synthesised using solid‐phase peptide synthesis. Circular dichroism and UV‐melting analyses confirmed the formation of a stable, sequence‐specific PNA‐RNA heteroduplex with miRNA‐221‐5p. This demonstrated strong hybridisation and high thermodynamic stability compared to scrambled control sequences. Cell proliferation assays indicated modest but reproducible antiproliferative effects for the CPP‐PNA conjugates co‐incubated with chloroquine, with no evidence of acute cytotoxicity. These findings emphasise the potential of CPP‐PNA systems for the intracellular delivery of antisense agents and highlight the importance of the linker nature in determining their biological performance.

Subjects

MeSH terms (MEDLINE)

Peptide Nucleic AcidsMicroRNAsCell-Penetrating PeptidesDrug DesignHumansCell Proliferation

Author keywords

SPPSantisense therapycell‐penetrating peptides (CPPs)click chemistrydisulfide bridgemiRNA‐221peptide nucleic acids (PNAs)

Substances

Peptide Nucleic AcidsMicroRNAsCell-Penetrating PeptidesMIR221, human

Authors and institutions

  • University of Naples Federico II, Naples, Italy.
  • Padova Unit, Institute of Biomolecular Chemistry of CNR, Padova, Italy.
  • Sorbonne Université, École Normale Supérieure, Université PSL, CNRS, Chimie Physique et Chimie du Vivant, CPCV, Paris, France.

ORCID profiles: Françoise Illien, Fabienne Burlina, Barbara Biondi

Cite

APA

Rotondo, M., Illien, F., Burlina, F., & Biondi, B. (2026). Design, Synthesis and Biophysical Characterisation of CPP‐PNA Conjugates for Targeting Oncogenic microRNA‐221. Journal of Peptide Science. https://doi.org/10.1002/psc.70129

Vancouver

Rotondo M, Illien F, Burlina F, Biondi B. Design, Synthesis and Biophysical Characterisation of CPP‐PNA Conjugates for Targeting Oncogenic microRNA‐221. Journal of Peptide Science. 2026. doi:10.1002/psc.70129

BibTeX
@article{Rotondo2026,
  author = {Rotondo, Martina and Illien, Françoise and Burlina, Fabienne and Biondi, Barbara},
  title = {Design, Synthesis and Biophysical Characterisation of CPP‐PNA Conjugates for Targeting Oncogenic microRNA‐221},
  journal = {Journal of Peptide Science},
  year = {2026},
  doi = {10.1002/psc.70129}
}
Start for free →